Abstract
The semi-rigid penile prosthesis (SRPP) is one of the treatment options for patients with end stage erectile dysfunction (ED). SRPPs are typically placed for either failure of conservative therapies or to provide a more permanent ED solution. In May 2019, Boston Scientific released its newest SRPP, the Tactra, constructed around a Nitinol core with dual-layer silicone construction. We highlight the initial experience with the Tactra from three high-volume implanting institutions. To present the initial experience of eleven patients with the Boston Scientific Tactra SRPP. Herein patient characteristics, surgical methods, intraoperative surgeon experience, postoperative follow up and implant characteristics are described. Eleven patients underwent placement of the Boston Scientific Tactra during June 2019 at three separate institutions. Indications for SRPP placement included: (1) initial implant placement for ED and ease of use, (2) current or previous IPP infection, mechanical malfunction or distal erosion. Patient characteristics, perioperative parameters and outcomes, and patient follow up were analyzed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
